Gonadal Disorders

10 registered clinical trials studyying Gonadal Disorders — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	A Novel Ovarian Reserve Monitoring Algorithm for Patients at Risk of Ovarian Injury From Gonadotoxic Therapy NCT05048654	University of Colorado, Denver	—
Recruiting	Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury NCT04460872	North Florida Foundation for Research and Education	Phase 2
Unknown	Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian NCT04556071	Xiaoxiang Chen	Phase 2
Completed	Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer NCT03562897	Catalysis SL	Phase 2
Completed	Avelumab in Refractory Testicular Germ Cell Cancer. NCT03403777	National Cancer Institute, Slovakia	Phase 2
Terminated	A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hy NCT03335254	TesoRx Pharma, LLC	Phase 1 / Phase 2
Terminated	Testosterone Plus Finasteride Treatment After Spinal Cord Injury NCT02248701	VA Office of Research and Development	Phase 2
Completed	Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycy NCT00947713	Royan Institute	Phase 1 / Phase 2
Completed	The Effect of Testosterone on Mood and Quality of Life NCT00202462	Seattle Institute for Biomedical and Clinical Research	N/A
Completed	Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions W NCT00341458	National Cancer Institute (NCI)	—